Subscribe
europe-istock-468428817
slavemotion / iStockphoto.com
25 April 2018Big Pharma

AG opines on ‘thorny issue’ in Truvada SPC clash

Advocate General Melchior Wathelet has advised the Court of Justice of the European Union (CJEU) on a case involving a supplementary protection certificate (SPC).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
CJEU clarifies ‘basic patent’ meaning in SPC dispute
25 July 2018   Earlier today, the Court of Justice of the European Union clarified when a product is ‘protected by a basic patent’ within the meaning of article 3(a) of the SPC regulation.
Big Pharma
Swiss Federal Supreme Court to adopt EU SPC case law
28 June 2018   Switzerland’s highest court held that new supplementary protection certificates for combination products should be governed by the relevant EU law, in a dispute over a Swiss SPC owned by Gilead Sciences.
Big Pharma
French court knocks out Gilead Truvada SPC
4 June 2018   The Paris Court of First Instance has nullified a supplementary protection certificate covering Gilead’s HIV/AIDS treatment Truvada.


Editor's picks

Astellas win strengthens blockbuster drug's European position
Europe
Astellas win strengthens blockbuster drug's European position
20 August 2025

Editor's picks

Europe
Astellas win strengthens blockbuster drug's European position
20 August 2025
Americas
Latham steps into dispute over $6bn treatment, replacing Kirkland
13 August 2025
Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025
Europe
In-house with Bayer: ‘Focus on quality early and stay close to inventors’
15 July 2025
Africa
Explainer: ARIPO’s role in Plant Variety Protection
15 July 2025
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

More on this story

Big Pharma
CJEU clarifies ‘basic patent’ meaning in SPC dispute
25 July 2018   Earlier today, the Court of Justice of the European Union clarified when a product is ‘protected by a basic patent’ within the meaning of article 3(a) of the SPC regulation.
Big Pharma
Swiss Federal Supreme Court to adopt EU SPC case law
28 June 2018   Switzerland’s highest court held that new supplementary protection certificates for combination products should be governed by the relevant EU law, in a dispute over a Swiss SPC owned by Gilead Sciences.
Big Pharma
French court knocks out Gilead Truvada SPC
4 June 2018   The Paris Court of First Instance has nullified a supplementary protection certificate covering Gilead’s HIV/AIDS treatment Truvada.

More on this story

Big Pharma
CJEU clarifies ‘basic patent’ meaning in SPC dispute
25 July 2018   Earlier today, the Court of Justice of the European Union clarified when a product is ‘protected by a basic patent’ within the meaning of article 3(a) of the SPC regulation.
Big Pharma
Swiss Federal Supreme Court to adopt EU SPC case law
28 June 2018   Switzerland’s highest court held that new supplementary protection certificates for combination products should be governed by the relevant EU law, in a dispute over a Swiss SPC owned by Gilead Sciences.
Big Pharma
French court knocks out Gilead Truvada SPC
4 June 2018   The Paris Court of First Instance has nullified a supplementary protection certificate covering Gilead’s HIV/AIDS treatment Truvada.

More features

UPC sees rising small molecule litigation with Pfizer in the hot seat
Why the Caribbean cannabis economy is ripe for IP protection
China filings push rise in patent applications in Ireland
Brain disorder medtech rivals butt heads at ITC
‘This is not a rescue deal’: How an acquisition fits London firm's plan
Alston & Bird partner with strong Japanese ties jumps to new firm
Chinese invisible braces maker hits back at infringement claims
Renowned ITC litigator leaves Morgan Lewis to join competitor